Ozempic Injection is a brand name for a medication that contains semaglutide. It is prescribed to improve blood sugar control in adults with type 2 diabetes. The active ingredient semaglutide works by mimicking the hormone glucagon-like peptide-1 to stimulate insulin release. Activation of the glp-1 receptor enhances insulin secretion, suppresses glucagon output, and slows gastric emptying, contributing to lower post-prandial glucose levels. These combined actions reduce overall blood glucose and also support modest weight loss through decreased appetite. The drug is administered subcutaneously and provides sustained glycemic effect when used consistently.

Ozempic Injection is a brand name for a medication that contains semaglutide, a synthetic analog of the human incretin hormone glp-1. It is prescribed primarily to improve blood glucose control in adults with type 2 diabetes mellitus. The drug works by mimicking the action of glp-1, which stimulates insulin release from pancreatic beta cells when glucose levels rise. Simultaneously, it suppresses glucagon secretion, reducing the amount of glucose produced by the liver. These combined effects lead to lower fasting and post-prandial blood sugar concentrations. Ozempic also slows gastric emptying, which contributes to a greater sense of satiety and can aid in weight management. The medication binds to glp-1 receptors in the pancreas, brain, and other tissues, activating signaling pathways that regulate appetite and energy expenditure. Over time, sustained activation of these receptors improves beta-cell function and may support long-term glycemic stability.

Ozempic Injection may cause nausea in some users. Headache can also occur occasionally. Some people experience diarrhea or constipation. Fatigue is another reported side effect. Mild skin reactions at the injection site are possible. Changes in taste sensation have been observed. These effects are generally mild and temporary.

Ozempic Injection may cause mild nausea in some patients. Headache can also occur as a frequent side effect. Fatigue is reported by a modest number of users. Diarrhea often appears during the first weeks of treatment. Constipation is another gastrointestinal reaction observed. Injection site reactions such as redness or swelling are common. Some individuals experience a decreased appetite as a result of the medication.